Technically Speakin...
Health Care: Drugs
Biosante Pharmaceuticals Inc. (BPAX: NASDAQ)
$2.22 -0.09 | -3.90%
06/04/12 - 11:29 AM ET
Company Income Statement
| Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | |
| Sales | 435.16K | 2.47M | 1.26M | 3.78M |
| Cost of Sales | 50.00K | 268.75K | 0.00 | 0.00 |
| Gross Operating Profit | 385.16K | 2.21M | 1.26M | 3.78M |
| Selling, General, and Administrative Expenses | 6.98M | 5.94M | 5.67M | 5.96M |
| Research & Development | 44.18M | 39.71M | 13.68M | 15.79M |
| Operating Income before D & A (EBITDA) | -50.78M | -43.44M | -18.10M | -17.97M |
| Depreciation & Amortization | 148.24K | 167.99K | 137.28K | 43.00K |
| Interest Income | 8.33K | 12.66K | 11.65K | 588.00K |
| Other Income - Net | -8.43K | -1.91M | -20.16M | 0.00 |
| Special Income / Charges | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Income Before Interest Expenses (EBIT) | -50.93M | -45.51M | -47.38M | -17.42M |
| Interest Expense | 681.57K | 688.08K | 147.02K | 0.00 |
| Pre-Tax Income | -51.61M | -46.20M | -47.53M | -17.42M |
| Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing Operations | -51.61M | -46.20M | -47.53M | -17.42M |
| Net Income From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Total Operations | -51.61M | -46.20M | -47.53M | -17.42M |
| Extraordinary Income/Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Cum. Effect of Acct. Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Income From Tax Loss Carryforward | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Net Income | -51.61M | -46.20M | -47.53M | -17.42M |
| Normalized Income (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-51.61M | -46.20M | -38.53M | -17.42M |
| Preferred Dividends | ||||
|---|---|---|---|---|
| Net Income Available To Common | -51.61M | -46.20M | -47.53M | -17.42M |
| Basic EPS from Continuing Ops. | -0.52 | -0.70 | -1.40 | -0.64 |
| Basic EPS from Discontinued Ops. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Total Operations | -0.52 | -0.70 | -1.40 | -0.64 |
| Basic EPS from Extraordinary Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Tax Loss Carryf'd. | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS from Other Gains (Losses) | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic EPS, Total | -0.52 | -0.70 | -1.40 | -0.64 |
| Basic Normalized Net Income/Share | -0.52 | -0.70 | -1.13 | -0.64 |
| EPS fr Continuing Ops. | -0.52 | -0.70 | -1.40 | -0.64 |
| EPS fr Discontinued Ops | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Total Ops. | -0.52 | -0.70 | -1.40 | -0.64 |
| EPS fr Extraord. Inc. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Cum Effect of Accounting Change | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Tax Loss Carfd. | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS fr Other Gains (L) | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS, Total | -0.52 | -0.70 | -1.40 | -0.64 |
| Diluted Normalized Net Inc/Shr (Net Income From Continuing Operations, Ex. Special Income / Charge) |
-0.52 | -0.70 | -1.13 | -0.64 |
| Dividends Paid per Share | 0.00 | 0.00 | 0.00 | 0.00 |
Portfolios with BPAX
- Portfolio NameUser Type
- UserSaveyn walter
- User2012_03
- Userwayne120
- ContributorBreakout Stocks Of The Week...
- UserDunDon1
- Contributor6 Drug Stocks Unworthy of B...
- Contributor3 Small-Cap Stocks on Insid...
- Contributor13 Biotech Stocks Bought an...
- UserSMITTY
- Contributor10 Most Shorted Stocks in B...
Latest BPAX Headlines from TheStreet
- Biosante Stock Gaps Down On Today's Open (BPAX) 06.01.12 | 09:06 am
- Biotech Twitter Mailbag: Gilead, Chelsea, Keryx, Onyx, BioSante, Dendreon 02.29.12 | 06:02 am
- Transocean, Netflix, BioSante Are Market Movers 02.27.12 | 05:02 pm
- Biotech Stock Mailbag: Vivus, Chelsea, BioCryst 02.17.12 | 05:02 am
- BioSante: A Penny Stock Still Overvalued 02.16.12 | 07:02 am
- 6 Drug Stocks Unworthy of Biotech Bull Market 02.07.12 | 12:02 pm
- Biosante Stock Falls On Unusually High Volume (BPAX) 02.07.12 | 11:02 am
- Biotech Stock Live Chat: 2012 Preview 12.15.11 | 11:12 am
- Market Preview: The Year Without a Santa Claus Rally 12.14.11 | 08:12 pm
- Novellus, BioSante: After-Hours Trading 12.14.11 | 07:12 pm
Press Releases for BPAX
- BioSante Pharmaceuticals, Inc. To Present At Jefferies Global Healthcare Conference - Business Wire 06.04.12 | 07:06 am
- BioSante Pharmaceuticals Announces Reverse Stock Split In Order To Maintain NASDAQ Listing - Business Wire 05.31.12 | 08:05 pm
- BioSante Pharmaceuticals Reports First Quarter Financial Results - Business Wire 05.08.12 | 04:05 pm
- Deadline Approaching: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In BioSante Pharmaceuticals, Inc. Of Class Action Lawsuit And The Deadline Of April 6, 2012 To Seek A Lead Plaintiff Position - PR Newswire 04.04.12 | 05:04 pm
- Deadline Approaching: The Law Firm Of Levi & Korsinsky Notifies Investors With Losses On Their Investment In BioSante Pharmaceuticals, Inc. Of Class Action Lawsuit And The Deadline Of April 6, 2012 To Seek A Lead Plaintiff Position - Business Wire 04.03.12 | 02:04 pm
- BioSante Pharmaceuticals Alert: The Briscoe Law Firm And Powers Taylor, LLP Investigate Possible Breaches Of Fiduciary Duty By The Officers And Directors Of BioSante Pharmaceuticals, Inc. - Business Wire 03.29.12 | 05:03 pm
- BioSante Pharmaceuticals Announces Positive Pill-Plus™ Data Presentation - Business Wire 03.20.12 | 07:03 am
- BioSante Pharmaceuticals Reports Financial Results For 2011 And Corporate Highlights - Business Wire 03.13.12 | 05:03 pm
- BioSante Pharmaceuticals, Inc. To Present At Roth Health Care Conference - Business Wire 03.09.12 | 07:03 am
- BioSante’s Prostate Cancer Vaccine Resulted In Stable Disease In Over 50% Of Patients In Newly Published Study - Business Wire 03.05.12 | 07:03 am
Partner Headlines for BPAX
- Alimera Sciences: An Upcoming Catalyst Should Make For A Nice Stock Gain - Seeking Alpha 03.26.12 | 09:03 am
- Bio-Pharma Watch List: 2 Week Report Card - Seeking Alpha 03.12.12 | 09:03 am
- What BioSante's Balance Sheet Says About Future R&D - Seeking Alpha 03.01.12 | 08:03 am
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
- 3 Biotechs Hopefully To Get Rich Or Die Trying - Seeking Alpha 01.04.12 | 08:01 am
- Singular Research Drops Coverage on BioSante Pharma After LibGel Results - Benzinga 12.16.11 | 04:12 pm
- Singular Research Reiterates BioSante Pharmaceuticals Buy, Maintains PT - Benzinga 12.13.11 | 01:12 pm
- 7 Stocks Trading Below $6 With Heavy Insider Buying - Seeking Alpha 12.08.11 | 09:12 am
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Do These Small-Cap Insiders Know Something You Don't? - Seeking Alpha 11.20.11 | 08:11 am
